Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation

Nature Medicine

Volumn 8, Issue 10, 2002, Pages 1115-1121

  John, Gareth R ^a   Shankar, Sai Latha ^a   Shafit Zagardo, Bridget ^a   Massimi, Aldo ^a   Lee, Sunhee C ^a   Raine, Cedric S ^a   Brosnan, Celia F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NOTCH RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL HYPERPLASIA; CELL MATURATION; CONTROLLED STUDY; DEMYELINATING DISEASE; EXTRACELLULAR MATRIX; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIPLE SCLEROSIS; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REMYELINIZATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; ASTROCYTES; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MAMMALIA;

EID: 0036799650     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm781     Document Type: Article

References (31)

1. Prineas, J.W. & McDonald, W.I. Demyelinating diseases. in Greenfield's Neuropathology, 6th edn. (eds. Graham, D.I. & Lantos, P.L.) 813-896 (Arnold, London 1997).
2. Raine, C.S. Demyelinating diseases. in Textbook of Neuropathology 3rd edn. (eds. Davis R.L. and Robertson, D.M.) 243-287 (Williams & Wilkins, Baltimore, 1997).
3. Wolswijk, G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18, 601-609 (1998)
4. Chang, A., Tourtellotte, W.W., Rudick, R. & Trapp, B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165-73 (2002)
5. Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Cho, E.S. & Sharer, L.R. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab. Invest. 63, 624-636 (1990)
6. Brosnan, C.F. & Raine, C.S. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6, 243-257 (1996).
7. Ohtsuka, T. et al. Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation. EMBO J. 18, 2196-2207 (1999).
8. Wang, S. et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21, 63-75 (1998).
9. Kondo, T. & Raff M.C. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 127, 2989-2998 (2000).
10. Givogri, M.I. et al. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J. Neurosci. Res. 67, 309-320 (2002).
11. Raine, C.S. The neuropathology of multiple sclerosis. in Multiple Sclerosis: Clinical and Pathogenetic Basis (eds. Raine, C.S., McFarland, H.F. & Tourtelotte, W.W.) 151-172 (Chapman & Hall, London, UK, 1997).
12. Baranzini, S.E. et al. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J. Immunol. 165, 6576-6582 (2000).
13. Cannella, B. & Raine, C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435 (1995).
14. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Med. 8, 500-508 (2002).
15. McCartney-Francis, N.L., Frazier-Jessen, M. & Wahl, S.M. TGF-β: A balancing act. Int. Rev. Immunol. 16, 553-580 (1998).
16. Blobe, G.C., Schiemann, W.P. & Lodish, H.F. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358 (2000).
17. Lee, S.C. & Brosnan, C.F. Molecular biology of glia: Astrocytes. in Molecular Biology of Multiple Sclerosis (ed. Russell, W.C.) 71-96 (John Wiley & Sons, New York, 1997).
18. Luster, A.D. & Ravetch, J.V. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166, 1084-1097 (1987)
19. Gray, G.E. et al. Human ligands of the Notch receptor. Am. J. Pathol. 154, 785-794 (1999).
20. Bottinger, E.P. et al. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 5877-5882 (1996).
21. McDonald, W.I. & Sears, T.A. Effect of demyelination on conduction in the central nervous system. Nature 221, 182-183 (1969).
22. Smith, K.J., Blakemore, W.F. & McDonald, W.I. Central remyelination restores secure conduction. Nature 280, 395-396 (1979).
23. Trapp, B.D. et al. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285 (1998).
24. Logan, A. et al. Effects of transforming growth factor β1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6, 355-363 (1994).
25. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
26. estan, N., Artavanis-Tsakonas, S. & Rakic, P. Contact-dependent inhibition of cortical neurite growth mediated by Notch signaling. Science 286, 741-746 (1999).
27. Redmond, L., Oh, S.-R., Hicks, C., Weinmaster, G. & Ghosh, A. Nuclear Notch1 signaling and the regulation of dendritic development. Nature Neurosci. 3, 30-40 (2000).
28. Liu, J.S.H., Zhao, M-L., Brosnan, C.F. & Lee, S.C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: Role of IL-1β and IL-1 receptor antagonist. J. Immunol. 157, 3569-3576 (1996).
29. Stears, R.L., Getts, R.C. & Gullens, S.R. A novel, sensitive detection system for highdensity microarrays using dendrimer technology. Physiol. Genomics 3, 93-99 (2001).
30. Lassmann, H., Raine, C.S., Antel, J. & Prineas, J.W. Immunopathology of multiple sclerosis: Report on an international meeting at the Institute of Neurology at the University of Vienna. J. Neuroimmunol. 86, 213-217 (1998).
31. Wu, E. & Raine, C.S. Multiple sclerosis: Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab. Invest. 67, 88-99 (1992).